Free Trial

Crossmark Global Holdings Inc. Sells 6,525 Shares of Genpact Limited (NYSE:G)

Genpact logo with Computer and Technology background

Crossmark Global Holdings Inc. trimmed its stake in Genpact Limited (NYSE:G - Free Report) by 1.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 389,739 shares of the business services provider's stock after selling 6,525 shares during the quarter. Crossmark Global Holdings Inc. owned about 0.22% of Genpact worth $19,635,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in shares of Genpact by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider's stock valued at $728,539,000 after buying an additional 61,376 shares during the last quarter. Franklin Resources Inc. boosted its holdings in Genpact by 1.3% during the fourth quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider's stock worth $180,560,000 after purchasing an additional 55,771 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Genpact by 5.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,848,449 shares of the business services provider's stock worth $165,288,000 after purchasing an additional 208,759 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Genpact by 3.6% during the fourth quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider's stock worth $170,175,000 after purchasing an additional 133,938 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Genpact by 8.7% during the fourth quarter. JPMorgan Chase & Co. now owns 3,400,636 shares of the business services provider's stock worth $146,057,000 after purchasing an additional 271,295 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have commented on G shares. Needham & Company LLC reaffirmed a "buy" rating and issued a $50.00 price objective on shares of Genpact in a research report on Monday, June 30th. Wall Street Zen raised shares of Genpact from a "buy" rating to a "strong-buy" rating in a research report on Friday, June 6th. Mizuho lifted their price objective on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. Finally, Robert W. Baird lowered their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Four investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $50.14.

Read Our Latest Analysis on Genpact

Insider Activity at Genpact

In other Genpact news, Director Nicholas C. Gangestad bought 2,000 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were purchased at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the acquisition, the director owned 2,000 shares in the company, valued at approximately $87,940. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 2.80% of the company's stock.

Genpact Trading Up 0.2%

NYSE:G traded up $0.09 during trading hours on Tuesday, hitting $46.15. The company had a trading volume of 1,389,076 shares, compared to its average volume of 1,415,993. The company has a market capitalization of $8.07 billion, a PE ratio of 15.75, a price-to-earnings-growth ratio of 2.01 and a beta of 0.94. The stock has a 50-day moving average price of $44.21 and a 200 day moving average price of $47.01. Genpact Limited has a 52 week low of $30.38 and a 52 week high of $56.76. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.45 and a quick ratio of 2.45.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. The business had revenue of $1.21 billion for the quarter, compared to analysts' expectations of $1.21 billion. Genpact had a net margin of 10.88% and a return on equity of 22.35%. The firm's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.73 earnings per share. On average, equities research analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Wednesday, June 18th were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend was Wednesday, June 18th. Genpact's dividend payout ratio (DPR) is presently 23.21%.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines